PAMPERO

Rendu-Osler disease, also known as Hereditary Hemorrhagic Telangiectasia (HHT), is a rare genetic vascular disorder. Despite significant improvements in screening and management, the disease can still severely affect patients’ quality of life and prognosis.

The project aims to transfer data collected over the past 15 years into the France Cohortes information system and to enrich them with complementary datasets.

Their analysis, supported by machine learning tools, will help provide new methods to identify prognostic factors and to predict patient response to treatment.

Scientific and Technical Lead:
Dr. Sophie DUPUIS-GIROD, Department of Genetics – Hôpital Femme Mère Enfant – Hospices Civils de Lyon (HCL), Reference Center for Rendu-Osler Disease, Lyon